Compare PSTG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSTG | BNTX |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0B | 25.5B |
| IPO Year | 2015 | 2019 |
| Metric | PSTG | BNTX |
|---|---|---|
| Price | $61.06 | $91.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 13 |
| Target Price | $91.37 | ★ $134.15 |
| AVG Volume (30 Days) | ★ 3.4M | 1.1M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.16 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $3,168,164,000.00 | N/A |
| Revenue This Year | $21.46 | N/A |
| Revenue Next Year | $15.71 | $2.61 |
| P/E Ratio | $236.46 | ★ N/A |
| Revenue Growth | ★ 11.92 | N/A |
| 52 Week Low | $34.51 | $79.81 |
| 52 Week High | $100.59 | $124.00 |
| Indicator | PSTG | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 35.49 |
| Support Level | $52.60 | N/A |
| Resistance Level | $76.63 | $112.30 |
| Average True Range (ATR) | 3.46 | 3.29 |
| MACD | -0.40 | -1.97 |
| Stochastic Oscillator | 14.25 | 34.40 |
Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue, which includes the sale of integrated storage hardware and embedded operating system software; and subscription services revenue, which includes Evergreen Storage subscriptions, a unified subscription that includes Pure as-a-Service, Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.